New drug SL-325 tested in healthy volunteers for safety
Knowledge-focused
Ongoing
This early-stage study is testing a new drug, SL-325, in 72 healthy volunteers to see if it is safe and how the body processes it. Participants receive either the drug or a placebo, and researchers monitor for side effects. This study does not aim to treat any disease but to gath…
Phase: PHASE1 • Sponsor: Shattuck Labs, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC